These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3830751)

  • 1. Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen.
    Custer RP; Sorof S
    Differentiation; 1985; 30(2):176-81. PubMed ID: 3830751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes.
    Custer RP; Sorof S
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6738-42. PubMed ID: 6593726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes.
    Sorof S; Custer RP
    Cancer Res; 1987 Jan; 47(1):210-20. PubMed ID: 3791207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes.
    Bassuk JA; Tsichlis PN; Sorof S
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7547-51. PubMed ID: 3478711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nucleosomal protein in normal liver related to the cytoplasmic polypeptide target of a carcinogen.
    Bassuk JA; Sorof S
    Mol Cell Biochem; 1985 Sep; 68(1):49-57. PubMed ID: 4058425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late target protein of the carcinogen N-2-fluorenylacetamide in rat liver.
    Munir KM; Blackburn GR; Sorof S
    Cancer Res; 1988 Dec; 48(23):6745-52. PubMed ID: 3180085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen.
    Vinores SA; Churey JJ; Haller JM; Schnabel SJ; Custer RP; Sorof S
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2092-6. PubMed ID: 6585789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal hepatocytes exhibiting histone H3 with antibody accessible sites that are cryptic in carcinogen-altered hepatocytes.
    Munir KM; Custer RP; Sorof S
    Cancer Res; 1989 Jan; 49(2):424-32. PubMed ID: 2910459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
    Hayes MA; Roberts E; Safe SH; Farber E; Cameron RG
    J Natl Cancer Inst; 1986 Apr; 76(4):683-91. PubMed ID: 2870208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
    Sell S; Becker FF; Leffert HL; Watabe L
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4239-49. PubMed ID: 61804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival.
    Seglen PO
    Cell Biol Toxicol; 1997 Jul; 13(4-5):301-15. PubMed ID: 9298250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells responsible for liver mass regeneration in rats with 2-acetylaminofluorene/partial hepatectomy injury.
    Chien CS; Chen YH; Chen HL; Wang CP; Wu SH; Ho SL; Huang WC; Yu CH; Chang MH
    J Biomed Sci; 2018 Apr; 25(1):39. PubMed ID: 29695258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM; Klaiber M; Parker SE; Farber E
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol.
    Yager JD; Zurlo J; Sewall CH; Lucier GW; He H
    Carcinogenesis; 1994 Oct; 15(10):2117-23. PubMed ID: 7955042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiography of "oval cells" appearing rapidly in the livers of rats fed N-2-fluorenylacetamide in a choline devoid diet.
    Sell S; Osborn K; Leffert HL
    Carcinogenesis; 1981; 2(1):7-14. PubMed ID: 7273292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
    Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen.
    Blackburn GR; Andrews JP; Rao KV; Sorof S
    Cancer Res; 1980 Dec; 40(12):4688-93. PubMed ID: 7438100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
    Williams GM; Watanabe K
    J Natl Cancer Inst; 1978 Jul; 61(1):113-21. PubMed ID: 276621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K; Maeura Y; Williams GM
    Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat.
    Hu Z; Evarts RP; Fujio K; Marsden ER; Thorgeirsson SS
    Am J Pathol; 1993 Jun; 142(6):1823-30. PubMed ID: 8506951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.